Cytokinetics
CYTK
CYTK
94 hedge funds and large institutions have $133M invested in Cytokinetics in 2015 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 27 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
14% less capital invested
Capital invested by funds: $155M → $133M (-$21.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
94
Holding in Top 10
–
Calls
$1.58M
Puts
$1.52M
Top Buyers
| 1 | +$1.94M | |
| 2 | +$1.73M | |
| 3 | +$1.13M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$982K |
| 5 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
+$777K |
Top Sellers
| 1 | -$3.95M | |
| 2 | -$2.28M | |
| 3 | -$2.19M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.37M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$875K |